Emmanuel Papadakis Analyst PerformanceAnalyst at Deutsche Bank AktiengesellschaftEmmanuel Papadakis is a stock analyst at Deutsche Bank Aktiengesellschaft focused in the medical sector, covering 6 publicly traded companies. Over the past year, Emmanuel Papadakis has issued 2 stock ratings, including and buy recommendations. While full access to Emmanuel Papadakis' proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Emmanuel Papadakis' coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings19 Last 8 YearsBuy Recommendations40.00% 6 Buy RatingsCompanies Covered6 Unique Companies Ratings Distribution15RatingsDistribution of strong buy, buy, hold, and sell ratings by Emmanuel Papadakis.RatingPercentageCount Strong Buy0.0%0 ratings Buy40.0%6 ratings Hold46.7%7 ratings Sell13.3%2 ratingsOut of 15 total stock ratings issued by Emmanuel Papadakis at Deutsche Bank Aktiengesellschaft, the majority (46.7%) have been Hold recommendations, followed by 40.0% Buy and 13.3% Sell.Best & Worst CallsBest Call000.0%NVONov 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call00.0%AZNJul 2017Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNYSE50.0% of companies on NYSE3 companiesNASDAQ33.3% of companies on NASDAQ2 companiesOTCMKTS16.7% of companies on OTCMKTS1 companyEmmanuel Papadakis, an analyst at Deutsche Bank Aktiengesellschaft, currently covers 6 companies listed on NYSE, NASDAQ and OTCMKTS, with the majority traded on NYSE.Coverage FocusSector IconSectorPercentageMedical5 companies83.3%Manufacturing1 company16.7%Emmanuel Papadakis of Deutsche Bank Aktiengesellschaft specializes in stock coverage within the Medical sector, with additional focus on Manufacturing companies.Coverage IndustriesIndustryPercentageLARGE CAP PHARMA3 companies50.0%MED - BIOMED/GENE1 company16.7%PHARMACEUTICAL PREPARATIONS1 company16.7%Miscellaneous1 company16.7% Emmanuel Papadakis' Ratings History at Deutsche Bank Aktiengesellschaft Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsSNYSanofi1/16/2026Reiterated Rating$46.58Buy$0.0000.00% ROISNYSanofi9/2/2025Upgrade$49.48Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenUBS GroupCitigroupBarclaysMorgan StanleyWells Fargo & CompanyRoyal Bank Of CanadaJPMorgan Chase & Co.Jefferies Financial GroupThe Goldman Sachs GroupTruist FinancialTD CowenPiper SandlerRaymond James FinancialStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
